AGGRENOX is not metabolized through the CYP2C19 system, however we wanted to understand if it might be affected when provided as well as omeprazole,’ stated John Smith, MD, PhD, senior vice president for clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc. ‘We are pleased these data show that omperazole will not connect to AGGRENOX.’ Related StoriesWyss Institute, UMass synergy to develop drug-device mixture for treating bloodstream clots in stroke patientsMore analysis needed before recommending antidepressants, Alzheimer's disease medications for stroke recovery: StudyStudy shows post-stroke lack of speech could be recoveredThis multiple-dosage, open-label, randomized crossover study was performed in 60 healthy volunteers.The Kaiser Daily Health Policy Report is released for Kaisernetwork.org, a free provider of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Kaiser and Company Family Foundation. All rights reserved.
PRESS RELEASE BETHESDA, Md.‹ASHP recently released itsPharmacy Ambulatory Care Tracker reporting app and dashboard, which allows pharmacists to conveniently record all patient encounters on the smartphones or tablets and statement their data to a customizable dashboard. ThePACT app, which is normally available for free download by specific pharmacists, collects patient treatment data. When combined with subscription-structured online PACT Dashboard, the PACT app generates comprehensive reports that show healthcare administrators and additional stakeholders how pharmacists in ambulatory treatment settings improve individual outcomes and reduce costs.